Pharma-Bio Serv (PBSV) Cash from Operations Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn |
| 10 | Pharma-Bio Serv | - | - | 722,374.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | -21.64% |
| Oct 31, 2025 | -3.62% |
| Jul 31, 2025 | -27.97% |
| Apr 30, 2025 | 27.98% |
| Jan 31, 2025 | -17.96% |
| Oct 31, 2024 | 16.49% |
| Jul 31, 2024 | -1.34% |
| Apr 30, 2024 | 3.16% |
| Jan 31, 2024 | 39.77% |
| Oct 31, 2023 | -7.56% |
| Jul 31, 2023 | -10.70% |
| Apr 30, 2023 | -28.96% |
| Jan 31, 2023 | -9.17% |
| Oct 31, 2022 | -1.43% |
| Jul 31, 2022 | 33.95% |
| Apr 30, 2022 | 13.27% |
| Jan 31, 2022 | -30.36% |
| Oct 31, 2021 | 15.70% |
| Jul 31, 2021 | 58.53% |
| Apr 30, 2021 | -61.89% |
| Jan 31, 2021 | 52.07% |
| Oct 31, 2020 | -22.09% |
| Jul 31, 2020 | 40.61% |
| Apr 30, 2020 | -22.34% |
| Jan 31, 2020 | 66.72% |
| Jul 31, 2019 | -20.80% |
| Apr 30, 2019 | 1.38% |
| Jan 31, 2019 | -16.26% |
| Oct 31, 2018 | -31.24% |
| Jul 31, 2018 | 19.53% |
| Apr 30, 2018 | -36.29% |
| Jan 31, 2018 | 26.18% |
| Oct 31, 2017 | -28.74% |
| Jul 31, 2017 | -19.32% |
| Apr 30, 2017 | -55.59% |
| Jan 31, 2017 | 30.25% |
| Oct 31, 2016 | -10.19% |
| Jul 31, 2016 | -46.99% |
| Apr 30, 2016 | -7.02% |
| Jan 31, 2016 | -7.38% |
| Oct 31, 2015 | 18.97% |
| Jul 31, 2015 | 9.86% |